Last reviewed · How we verify
Hydrofol (docosanoic acid)
Hydrofol (generic name: docosanoic acid) is a docosanoic acid drug. It is currently in unknown development.
Hydrofol works by activating the peroxisome proliferator-activated receptor alpha (PPAR-alpha), a protein that regulates the expression of genes involved in lipid metabolism.
Hydrofol, also known as docosanoic acid, is a small molecule drug that targets the peroxisome proliferator-activated receptor alpha (PPAR-alpha). It is a member of the docosanoic acid class and its mechanism of action is not FDA approved. The exact indications for Hydrofol are unknown, and its commercial status, including patent status and generic availability, is also unclear. As a result, key safety considerations and pharmacokinetic properties, such as half-life and bioavailability, are not well established. Further research is needed to fully understand the potential benefits and risks of Hydrofol.
At a glance
| Generic name | docosanoic acid |
|---|---|
| Drug class | docosanoic acid |
| Target | Peroxisome proliferator-activated receptor delta, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor gamma |
| Therapeutic area | Metabolic |
| Phase | unknown |
Mechanism of action
Think of PPAR-alpha like a master switch that controls how your body uses fat. When Hydrofol activates this switch, it helps your body break down and use fat more efficiently, which can be beneficial for people with certain health conditions. This process also affects how your body produces energy and uses other nutrients.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hydrofol CI brief — competitive landscape report
- Hydrofol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Hydrofol
What is Hydrofol?
How does Hydrofol work?
What is the generic name of Hydrofol?
What drug class is Hydrofol in?
What development phase is Hydrofol in?
What does Hydrofol target?
Related
- Drug class: All docosanoic acid drugs
- Target: All drugs targeting Peroxisome proliferator-activated receptor delta, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor gamma
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing